The largest series of post TAVI coronary occlusion published

Original title: Predictive Factors, Management and Clinical Outcomes of Coronary obstruction Following Transcatheter Aortic Valve Implantation Insight From a Large Multicenter Registry Reference: Henrique B. Ribeiro, et; al. J Am Coll Cardiology 2013;62:1552-62

Percutaneous implantation of the aortic valve is a valid strategy in high-risk surgical patients. One of the possible complications of this procedure is the occlusion of the coronary arteries by displacing calcium during implantation.

In this multicenter registry 6688 patients were included, all received a percutaneous valve implantation, in 44 cases (0.66 %) symptomatic coronary occlusion was observed. Patients with this complication were older, women, higher EuroSCORE log, history of prior biological valve replacement and also more common balloon- expandable valves. By contrast, the history of previous myocardial revascularization surgery was a protective factor. Using CT they had a lower aortic area, smaller diameter at the sinotubular junction, and less distance between the valve and the coronary ostium (

Conclusion:

Occlusion of coronary arteries during implantation of an aortic valve (PCI) is a complication that compromises life, is more common in women, with expandable balloon valves in those who previously received biological valve. The low confinement of the Ostia and the sinuses of Valsalva physiognomies are anatomical factors associated with treatment success and also important to anticipate or prevent the occurrence of this complication.

Comment

Although coronary occlusion is rare, its presence adversely impacts directly on the immediate and short -term developments, in addition to prolonging hospitalization and the cost of the procedure. This complication is related to the anatomy of the valve and can be evaluated by CT. Proper patient selection, implant device and technological improvements of the new valves will decrease this eventuality.

Courtesy Dr Carlos Fava .
Interventional Cardiologist
Favaloro Foundation – Argentina

Dr. Carlos Fava para SOLACI.ORG

More articles by this author

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....

TAVR in Pure Native Aortic Regurgitation: Are Dedicated Devices Truly Superior?

This systematic meta-analysis assessed the efficacy and safety of transcatheter aortic valve replacement (TAVR) in patients with pure native aortic regurgitation. The emergence of...

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....